EPISODE · May 2, 2010 · 14 MIN
Podcast 85: B vitamins lower homocysteine levels, so why don’t they retard the progression of diabetic nephropathy?
from Clinical Conversations · host NEJM Group
A surprise finding: homocysteine is supposed to be a factor in vascular inflammation, but lowering hyperhomocysteinemia in patients with diabetic nephropathy actually accelerated the decline of their GFRs. What gives? We have a conversation with Dr. J. David Spence, whose results were just published in JAMA. Interview-related link: JAMA paper on the effect of B vitamins on diabetic nephropathy News-related links: Clopidogrel suffers possible class-effect interference from PPIs BMJ paper on hyperemesis gravidarum across generations High-test flu vaccine guidance from ACIP Brain games and the lack of data supporting their effectiveness The post Podcast 85: B vitamins lower homocysteine levels, so why don’t they retard the progression of diabetic nephropathy? first appeared on Clinical Conversations.
Embed this episode
What this episode covers
A surprise finding: homocysteine is supposed to be a factor in vascular inflammation, but lowering hyperhomocysteinemia in patients with diabetic nephropathy actually accelerated the decline of their GFRs. What gives? We have a conversation with Dr. J. David Spence, whose results were just published in JAMA. Interview-related link: JAMA paper on the effect of B vitamins on diabetic […]
NOW PLAYING
Podcast 85: B vitamins lower homocysteine levels, so why don’t they retard the progression of diabetic nephropathy?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.